Across TCGA pan-cancer cohorts, MIR519C RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR519C data layer.
The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MIR519C RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR519C expression acts as an unfavorable survival marker.
TGCT, PAAD, and BRCA are the cancer types where MIR519C RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.